ACADIA Pharmaceuticals Inc. (ACAD) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    ACADIA Pharmaceuticals In...

    NASDAQ: ACAD · Real-Time Price · USD
    21.05
    -0.16 (-0.75%)
    At close: Sep 26, 2025, 3:59 PM
    21.28
    1.09%
    After-hours: Sep 26, 2025, 06:02 PM EDT

    ACADIA Pharmaceuticals Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 319.59M 188.66M 114.85M 147.44M
    Short-Term Investments
    		 436.4M 250.21M 301.98M 373.27M
    Long-Term Investments
    		 n/a 5.77M 12.97M 9.37M
    Other Long-Term Assets
    		 78.87M 5.1M 5.31M 6.61M
    Receivables
    		 104.69M 102.35M 63.08M 65.34M
    Inventory
    		 21.95M 35.82M 6.64M 7.88M
    Other Current Assets
    		 n/a n/a n/a n/a
    Total Current Assets
    		 938.32M 616.13M 507.94M 617.82M
    Property-Plant & Equipment
    		 50.79M 56.47M 61.59M 66.31M
    Goodwill & Intangibles
    		 119.78M 65.49M n/a n/a
    Total Long-Term Assets
    		 249.44M 132.83M 79.88M 82.3M
    Total Assets
    		 1.19B 748.96M 587.81M 700.12M
    Account Payables
    		 16.19M 17.54M 12.75M 6.88M
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 n/a n/a n/a n/a
    Other Current Liabilities
    		 114.28M 92.31M 49.51M 39.27M
    Total Current Liabilities
    		 394.87M 254.25M 125.63M 96.07M
    Long-Term Debt
    		 n/a n/a n/a 56.13M
    Other Long-Term Liabilities
    		 18.06M 15.15M 9.07M -49.09M
    Total Long-Term Liabilities
    		 60.09M 62.95M 61.77M 63.16M
    Total Liabilities
    		 454.96M 317.2M 187.4M 159.23M
    Total Debt
    		 51.99M 57.2M 62M 56.13M
    Book Value
    		 732.79M 431.75M 400.41M 540.89M
    Book Value Per Share
    		 4.42 2.64 2.48 3.37
    Common Stock
    		 16K 16K 16K 16K
    Retained Earnings
    		 -2.2B -2.43B -2.37B -2.15B
    Comprehensive Income
    		 292K 24K -975K -192K
    Shareholders Equity
    		 732.79M 431.75M 400.41M 540.89M
    Total Investments
    		 436.4M 255.98M 301.98M 373.27M

    Add to Watchlist